Pan-KRAS-IN-13
Pan-KRAS-IN-13 (compound 2) is a potent inhibitor of KRAS, with IC50s of 2.75 nM and 2.89 nM for G12D and G12V, respectively[1]
Product Specifications
CAS Number
[3033637-76-9]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pan-kras-in-13.html
Solubility
10 mM in DMSO
Smiles
FC1=C(C#C)C2=C(C3=NC(OCC4)=C(C(N5[C@@H]4CNCC5)=NC(OC[C@]6(C[C@@H](F)C7)N7CCC6)=N8)C8=C3F)C=C(O)C=C2C=C1
Molecular Formula
C33H31F3N6O3
Molecular Weight
616.63
References & Citations
[1]Ildong Pharmaceutical Co., Ltd. Novel tetraheterocycle compound. World Intellectual Property Organization, WO2024063578 A1 2024-03-28
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P1001-31C5-ML405 100 µL
P53 DINP1 (p53 Dependent Damage-inducible Nuclear Protein 1, p53 Damage-inducible Nuclear Protein 1, p53DINP1, DKFZp434M1317, FLJ22139, p53 Inducible Nuclear Protein 1, p53 Inducible p53DINP1, Stress Induced Protein, SIP, Teap, Tumor Protein p53 Inducible Nuclear Protein 1, TP53DINP1, TP53INP1, TP53INP1A, TP53INP1B) (MaxLight 405) discontinued
Ask
View Details 